526 related articles for article (PubMed ID: 25151851)
21. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.
Lavorini F; Magnan A; Dubus JC; Voshaar T; Corbetta L; Broeders M; Dekhuijzen R; Sanchis J; Viejo JL; Barnes P; Corrigan C; Levy M; Crompton GK
Respir Med; 2008 Apr; 102(4):593-604. PubMed ID: 18083019
[TBL] [Abstract][Full Text] [Related]
22. Device errors in asthma and COPD: systematic literature review and meta-analysis.
Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M
NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682
[TBL] [Abstract][Full Text] [Related]
23. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
Respir Med; 2023; 219():107435. PubMed ID: 38652077
[TBL] [Abstract][Full Text] [Related]
24. Importance of inhaler devices in the management of airway disease.
Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
[TBL] [Abstract][Full Text] [Related]
25. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
26. A comparative analysis of errors in inhaler technique among COPD versus asthma patients.
Ocakli B; Ozmen I; Tunçay EA; Gungor S; Altinoz H; Adiguzel N; Sak ZA; Gungor G; Karakurt Z; Arbak P
Int J Chron Obstruct Pulmon Dis; 2018; 13():2941-2947. PubMed ID: 30288037
[TBL] [Abstract][Full Text] [Related]
27. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
[TBL] [Abstract][Full Text] [Related]
28. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
Molimard M; Till D; Stenglein S; Singh D; Krummen M
Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
[TBL] [Abstract][Full Text] [Related]
29. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
[TBL] [Abstract][Full Text] [Related]
30. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
[TBL] [Abstract][Full Text] [Related]
31. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
32. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
[TBL] [Abstract][Full Text] [Related]
33. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
34. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
Lau M; Young PM; Traini D
Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
[TBL] [Abstract][Full Text] [Related]
35. [Easyhaler--ideal dry powder inhaler].
Andrzej E; Małgorzata BE
Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
[TBL] [Abstract][Full Text] [Related]
36. Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors.
Luczak-Wozniak K; Dabrowska M; Domagala I; Miszczuk M; Lubanski W; Leszczynski A; Krenke R
Pulm Pharmacol Ther; 2018 Aug; 51():65-72. PubMed ID: 29964174
[TBL] [Abstract][Full Text] [Related]
37. [New dry powder inhalers].
Emeryk A; Pirożyński M
Pneumonol Alergol Pol; 2015; 83(1):83-7. PubMed ID: 25577539
[TBL] [Abstract][Full Text] [Related]
38. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
Pepper AN; Cooke A; Livingston L; Lockey RF
Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
[TBL] [Abstract][Full Text] [Related]
39. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
Gillespie M; Song S; Steinfeld J
Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
